Wednesday, September 28, 2022 10:53:58 AM
In a recent study published in @psychiatristcns, the evaluation of more than 400 patients showed that 72% of them saw improvement in their mood, and 38% were symptom-free after a #ketaminetreatment series.
— KetaMD (@keta_md) September 26, 2022
Via @WashingtonPost: https://t.co/7684gxOzGt pic.twitter.com/faYGyaNeC8
Recent BWVI News
- Form C/A - Offering Statement: [Amend] • Edgar (US Regulatory) • 11/01/2023 09:24:01 PM
- Will Shares of this Psycheceutical Pop on Dosing News? • AllPennyStocks.com • 07/13/2023 02:52:00 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM